Cartesian Therapeutics Inc — 財務諸表 (NASDAQ:RNAC) | MetaTrader

チャート全体を表示

ニュース

Cartesian Therapeutics, Inc. (RNAC) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

BTIGがCartesian Therapeutics株にBuy評価を継続、目標株価44ドル

BTIG reiterates Buy on Cartesian Therapeutics stock, $44 target

Mizuho、治験進展を受けてCartesian Therapeutics株の投資判断を維持

Mizuho reiterates Cartesian Therapeutics stock rating on trial progress

Kyverna Stock: The King Of The CAR-T Autoimmune Revolution (NASDAQ:KYTX)

Cartesian Therapeutics, Inc. (RNAC) Upgraded to Buy: What Does It Mean for the Stock?

Johnson & Johnson Touts Positive Results For Lupus Treatment - Johnson & Johnson (NYSE:JNJ)

2026 Market Outlook: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares

H.C.ワインライト、カーテシアン・セラピューティクスの株価目標を40ドルから30ドルに引き下げ

H.C. Wainwright lowers Cartesian Therapeutics stock price target to $30 from $40

Cartesian: Maintaining Buy Rating For Expansion Of Descartes-08 For Myositis (NASDAQ:RNAC)